Comparative analysis of “APTT vs RVVT” based activated protein C resistance assay in the diagnosis of Factor V Leiden mutation

Comparative analysis of “APTT vs RVVT” based activated protein C resistance assay in the diagnosis of Factor V Leiden mutation

Background: Thrombophilia is a hypercoagulable state characterized by increased venous thrombosis. The most common cause of heritable thrombophilia is Factor V Leiden (FVR506Q) homozygous state, with a relative risk of 10–80 times as compared to normal individuals and Lupus anticoagulant is the most...

Full description

Bibliographic Details
Main Author:	Mirza Asif Baig
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2020-01-01
Series:	Indian Journal of Pathology and Microbiology
Subjects:	activated protein c resistance activated partial thromboplastin time factor v leiden mutation lupus anticoagulant
Online Access:	http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2020;volume=63;issue=2;spage=247;epage=250;aulast=Baig

Similar Items

Comparative analysis of chromogenic vs clot.based one stage APTT assay for determination of factor VIII level
by: Mirza Asif Baig, et al.
Published: (2021-01-01)

Lupus anticoagulant in children – a confounding factor in diagnosis and targeted therapy
by: Jinca Cristian, et al.
Published: (2021-07-01)

Factor V Leiden homozygous mutation: Recurrent venous thromboembolism during periods of discontinuation of anticoagulant therapy
by: Sabira Šahinović, et al.
Published: (2021-08-01)

Transmission of lupus anticoagulant by allogeneic stem cell transplantation
by: Mira Romany Massoud, et al.
Published: (2014-07-01)

Factor V Leiden and Prothrombin Mutations in South of Iran
by: M Karimi, et al.
Published: (2007-01-01)

Factor V Leiden Mutation and Stroke
by: J Gordon Millichap
Published: (2001-11-01)

Diagnostic analysis of lupus anticoagulant using clot waveform analysis in activated partial thromboplastin time prolonged cases: A retrospective analysis
by: Kazunori Kanouchi, et al.
Published: (2021-06-01)

Successful Conservative Treatment of a Complicated Aortic Thrombus in a Woman with Factor V Leiden Mutation
by: Elise Frebutte, et al.
Published: (2021-06-01)

Factor V Leiden mutation: An added risk in single ventricle palliation
by: R Saileela, et al.
Published: (2012-01-01)

Factor V leiden mutation in Behcet’s disease and the relationship with clinical manifestations
by: Mowla K, et al.
Published: (2010-05-01)

Pengaruh Lama Pemberian Fondaparinux terhadap Activated Partial Thromboplastin Time (APTT) pada Pasien Sindroma Koroner Akut
by: Arina Dery Puspitasari, et al.
Published: (2019-07-01)

Evaluation of the Activated Partial Thromboplastin Time (aPTT) Sensitivity to Unfractionated Heparin Using Three Commercial Reagents: Implication for Therapeutic Range
by: Nisarat Opartkiattikul, et al.
Published: (2005-12-01)

In Vitro Anticoagulant Activity and Active Components of Safflower Injection
by: Kai-Hong Wang, et al.
Published: (2018-01-01)

Avascular necrosis in systemic lupus erythematosus: total hip replacement in a patient with mutation in clotting factor V (Leiden) gene, clinical observation
by: F. A. Cheldieva, et al.
Published: (2021-04-01)

Frequency of Factor V Leiden and Prothrombin Polymorphism in South of Iran
by: Javad Dehbozorgian, et al.
Published: (2009-06-01)

Arterial thrombosis associated with factor V leiden mutation in a child with nephrotic syndrome
by: Vamsi Krishna Nagalla, et al.
Published: (2021-01-01)

Ruling out lupus anticoagulants with mixing test–specific cutoff assessment and the index of circulating anticoagulant
by: Osamu Kumano, et al.
Published: (2019-10-01)

Lupus Antibody Mimicking Reduced Plasmatic Coagulation in a Patient With Atrial Fibrillation and Ischemic Stroke
by: Aydin Huseynov, et al.
Published: (2020-08-01)

Rare Trousseau’s Syndrome and Factor V Leiden Mutation With Ovary Carcinoma
by: Handan Mısırlı, et al.
Published: (2008-06-01)

Evaluation the frequency of factor V Leiden mutation in pregnant women with preeclampsia syndrome in an Iranian population
by: Azadeh Azinfar, et al.
Published: (2012-01-01)

Monitoring of Anticoagulant Therapy in Heart Disease: Considerations for the Current Assays
by: Mohammadali Boroumand, et al.
Published: (2010-04-01)

Monitoring of Anticoagulant Therapy in Heart Disease: Considerations for the Current Assays
by: Hamidreza Goodarzynejad, et al.
Published: (2010-05-01)

Prevalence and Clinical Significance of Factor V Leiden Mutation in Egyptian Preeclamptic Women
by: Ahmed Alsheikh, et al.
Published: (2021-01-01)

Pulmonary embolism due to factor V leiden mutation causing worsening of asthma
by: Kaushik Saha, et al.
Published: (2013-01-01)

Phytochemicals, Nutritional Value, Antioxidant, and Anticoagulant Activity of Lactuca sativa L. Leaves and Stems
by: Hanin Nafed Mughrbi, et al.
Published: (2020-08-01)

In vivo examination of the anticoagulant effect of the Brassica oleracea methanol extract
by: Khan Rafeeq Alam, et al.
Published: (2015-01-01)

Factor V Leiden mutation is not a predisposing factor for acute coronary syndromes
by: G. Himabindu, et al.
Published: (2012-11-01)

Recurrent Pregnancy Loss in a Subject with Heterozygote Factor V Leiden Mutation; a Case Report
by: Reza Ebrahimzadeh-Vesal, et al.
Published: (2014-05-01)

Updates on Anticoagulation and Laboratory Tools for Therapy Monitoring of Heparin, Vitamin K Antagonists and Direct Oral Anticoagulants
by: Osamu Kumano, et al.
Published: (2021-03-01)

The Effect of Oral Contraceptive Pills on The Gene Mutation of Factor V Leiden among Sudanese Women
by: Kawthar Abdelgaleil Mohammed Salih, et al.
Published: (2020-05-01)

Recurrent pregnancy loss: can factor V Leiden mutations be a cause
by: R R N Reddy, et al.
Published: (2019-05-01)

Unbelievable but true: Partial thromboplastin time, kaolin 120 s and yet no surgical bleed!
by: Shagun Bhatia Shah, et al.
Published: (2017-01-01)

A Young Aged Myocardial Infarction with Factor V Leiden Mutation and High Lipoprotein A Level
by: Abdulmelik Yildiz, et al.
Published: (2013-06-01)

Subarachnoid hemorrahage in a young patient with a factor V Leiden thrombophilia
by: Dana Turliuc, et al.
Published: (2013-06-01)

Freqüência do fator V Leiden em indivíduos sob investigação de trombofilia, Recife, Pernambuco, Brasil Frequency of factor V Leiden in individuals under thrombophilia investigation, Recife, Pernambuco, Brazil
by: Catarina P. S. Ramos, et al.
Published: (2006-06-01)

Study of some parameters of blood coagulation in patients with rheumatoid arthritis
by: Nuritdinova S. K.
Published: (2010-01-01)

FV Leiden mutation and deep venous thrombosis in Vojvodina: A case-control study
by: Salatić Iva, et al.
Published: (2011-01-01)

Factor V Leiden mutation and acquired activated protein C resistance in Indian women with recurrent fetal loss
by: Pallavi Sinha, et al.
Published: (2020-01-01)

Antithrombotic activity of Mentha longifolia in animal model
by: . Alamgeer, et al.
Published: (2018-03-01)

Factor V Leiden and prothrombin G20210A mutations and risk of vaso-occlusive complications in sickle cell disease: A meta-analysis through the lens of nephrology
by: Lakkakula VKS Bhaskar
Published: (2019-05-01)